Actively Recruiting
Losing and Regaining Control Over Drug Intake: General and Specific Pavlovian-to-Instrumental Transfer Effects in Substance Use Disorders
Led by Technische Universität Dresden · Updated on 2024-11-22
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
T
Technische Universität Dresden
Lead Sponsor
C
Charite University, Berlin, Germany
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating how Pavlovian-to-instrumental transfer (PIT) effects differ in people with moderate to severe substance use disorders (SUD), including alcohol, cannabis, methamphetamine, amphetamine, and cocaine use disorders, compared to healthy individuals. This study aims to understand behavioral and brain activity differences related to control over substance use, focusing on both general and specific PIT effects. The research builds on earlier findings suggesting that alcohol use disorder (AUD) patients show stronger specific PIT effects than healthy controls. Participants are divided into four groups: those with AUD alone, those with AUD plus comorbid SUD, those with SUD without AUD, and healthy controls. They will complete a full PIT task consisting of instrumental training, Pavlovian conditioning, a transfer phase, and query trials to assess explicit knowledge. Functional MRI (fMRI) and structural MRI scans will be used to examine brain activity and structure related to PIT. Psychological assessments and neuropsychological tests will also be conducted. A follow-up will occur three months later using online questionnaires to track substance use behavior. During the study, participants will undergo behavioral tasks and brain imaging to measure neural and behavioral PIT effects. They will complete interviews and questionnaires assessing substance use, mental health, and cognitive functions. The primary outcomes include neural PIT effects measured by fMRI and behavioral PIT effects from the task. The follow-up assesses alcohol and substance consumption three months after testing. Safety screenings, including breath alcohol tests and urine drug tests, will be performed at assessment. Participants will be involved for a single testing day plus the follow-up period.
CONDITIONS
Brief Title
Role of Pavlovian Mechanisms for Control Over Substance Use
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women between 18 and 65 years of age
- Meet 4 or more DSM-5 criteria for alcohol-related and/or substance-related disorder (cannabis, amphetamine, methamphetamine, or cocaine) without withdrawal symptoms
- Currently using alcohol without a desire for abstinence
- Ability to consent to the study and complete questionnaires
- Sufficient German language and motor skills for using a computer
- Existing health insurance
You will not qualify if you...
- Lifetime diagnosis of bipolar disorder, schizophrenia, or schizophrenia spectrum disorder (drug-induced cases must be more than one month ago)
- Current diagnosis of major depressive disorder or suicidal intention
- High risk ASSIST scores for substances other than alcohol, amphetamine, methamphetamine, cannabis, cocaine, or tobacco
- History of traumatic brain injury or severe neurological diseases such as dementia, Parkinson's disease, multiple sclerosis, epilepsy, meningitis, or stroke
- Pregnancy or breastfeeding
- Use of medications interacting with the dopamine system within 10 days before participation or less than four half-lives before the study
- MRI contraindications such as pacemakers, metallic implants, splinters, or surgical staples
- Color vision deficiency
- Sensorineural hearing loss of 30 dB or greater
- Tinnitus
- Acute intoxication with alcohol or substances on assessment day verified by tests
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo comprehensive psychological assessments and neuropsychological tests to evaluate substance use disorder and related behavioral characteristics.
1 visit (in-person)
Duration - 1 day
Participants complete the Pavlovian-to-instrumental transfer (PIT) paradigm while undergoing fMRI and sMRI scans to assess neural and behavioral correlates of substance use.
1 visit (in-person)
Duration - 3 months after testing
Participants complete online follow-up questionnaires 3 months after initial testing to assess clinical course and substance use.
1 follow-up online visit
Trial Site Locations
Total: 1 location
1
Department of Psychiatry and Psychotherapy, Technische Universität Dresden
Dresden, Germany
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4